Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.54 |
| ▸ | ESR1 | P03372 | 3/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | JAK2 | O60674 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30505635 | 0.88 | SLC6A3 (0.71) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL1979275 | 0.88 | SLC6A3 (0.71) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL11309362 | 0.86 | SLC6A3 (0.69) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL8777320 | 0.86 | SLC6A3 (0.69) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL6970918 | 0.86 | SLC6A3 (0.69) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL725404 | 0.85 | KMT2A (0.76) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL11874477 | 0.85 | PRSS1 (0.68) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL6948356 | 0.85 | SLC6A3 (0.72) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL1914132 | 0.85 | SLC6A3 (0.72) | SLC6A3KMT2AMAPTSMN1; SMN2GAA | |
| SCHEMBL26490187 | 0.85 | SLC6A3 (0.72) | SLC6A3KMT2AMAPTSMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 922 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2550285-B1 | TRIOXACARCINS AND USES THEREOF | HARVARD COLLEGE (US) | 2017-07-19 | — | — | EP | claimed |
| EP-1332150-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES AND USE THEREOF | Chattopadhyaya, Jyoti (SE) | 2003-08-06 | — | — | EP | claimed |
| WO-2002038578-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES AND USE THEREOF | CHATTOPADHYAYA JYOTI (SE) | 2002-05-16 | — | — | WO | claimed |
| WO-2024148274-A1 | COMPLEMENT INHIBITION | APELLIS PHARMACEUTICALS, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| EP-4396354-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | Wave Life Sciences Ltd. (SG) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024145281-A1 | BIODEGRADABLE LIPIDS AND FORMULATIONS FOR INTRAMUSCULAR, IN VITRO, AND EX VIVO TRANSFECTION OF MRNA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024119140-A1 | CLEAVABLE COMONOMER STRATEGY FOR ACCELERATING REMOVAL OF GEL NAIL POLISH | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024112854-A1 | INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| EP-4370132-A2 | MULTIPLEXING TARGETING LIGANDS THROUGH CLICK CHEMISTRY AT THE ANOMERIC SITE OF SUGARS | Alnylam Pharmaceuticals, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-4370136-A2 | SIMPLE CHEMICAL APPROACHES TO INTRODUCE 2,6-DIAMINOPURINE AND 2-AMINOADENINE CONJUGATES INTO OLIGONUCLEOTIDES | Alnylam Pharmaceuticals, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-4367125-A1 | AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH | Alnylam Pharmaceuticals, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2000032201-A2 | USE OF 17-KETOSTEROIDS FOR THE TREATMENT OF MALARIA AND TRYPANOSOMIASIS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000032177-A2 | USE OF 17-KETOSTEROIDS IN THE TREATMENT OF HEPATITIS C VIRUS AND OTHER TOGAVIRUS INFECTIONS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000032176-A2 | USE OF 17-KETOSTEROIDS FOR THE TREATMENT OF TOXOPLASMOSIS AND CRYPTOSPORIDOSIS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0648221-A4 | TRITYL MONITOR FOR AUTOMATED POLYNUCLEOTIDE SYNTHESIS. | APPLIED BIOSYSTEMS (US) | 1996-04-24 | — | — | EP | disclosed |
| EP-0648221-A1 | TRITYL MONITOR FOR AUTOMATED POLYNUCLEOTIDE SYNTHESIS | THE PERKIN-ELMER CORPORATION (US) | 1995-04-19 | — | — | EP | disclosed |
| EP-0595839-A4 | — | — | 1994-08-03 | — | — | EP | disclosed |
| EP-0595839-A1 | METHOD AND COMPOUNDS FOR RNA SYNTHESIS | THE PERKIN-ELMER CORPORATION (US) | 1994-05-11 | — | — | EP | disclosed |
| WO-1994000471-A1 | TRITYL MONITOR FOR AUTOMATED POLYNUCLEOTIDE SYNTHESIS | APPLIED BIOSYSTEMS, INC. (US) | 1994-01-06 | — | — | WO | disclosed |
| WO-1993001204-A1 | METHOD AND COMPOUNDS FOR RNA SYNTHESIS | APPLIED BIOSYSTEMS, INC. (US) | 1993-01-21 | — | — | WO | disclosed |